PCM
ANIP icon

Piermont Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Piermont Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-4,460
Closed -$298K – 121
2018
Q2 		$298K Sell
4,460
-880
-16% -$54.9K 0.09% 213
2018
Q1 		$311K Sell
5,340
-830
-13% -$52.7K 0.1% 221
2017
Q4 		$398K Sell
6,170
-360
-6% -$22.4K 0.13% 195
2017
Q3 		$343K Sell
6,530
-6,510
-50% -$310K 0.11% 215
2017
Q2 		$610K Sell
13,040
-2,250
-15% -$109K 0.17% 212
2017
Q1 		$757K Buy
15,290
+8,050
+111% +$452K 0.18% 192
2016
Q4 		$439K Sell
7,240
-140
-2% -$8.56K 0.1% 238
2016
Q3 		$490K Buy
+7,380
New +$462K 0.12% 237

Other funds holding ANIP

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $12B AUM 34.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return